A31. REAL WORLD ASTHMA TREATMENT OUTCOMES, BIOMARKER STUDIES, PHENOTYPING, AND SEVERITY ASSESSMENTS最新文献

筛选
英文 中文
Serum Iron Correlates with Serum Immunoglobulin E, Serum Total Globulin, and Exhaled Nitric Oxide in Asthmatic Children 哮喘儿童血清铁与血清免疫球蛋白E、血清总球蛋白和呼出一氧化氮的相关性
A31. REAL WORLD ASTHMA TREATMENT OUTCOMES, BIOMARKER STUDIES, PHENOTYPING, AND SEVERITY ASSESSMENTS Pub Date : 2022-05-01 DOI: 10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a1238
S.-W. Hu, A. J. Ghio
{"title":"Serum Iron Correlates with Serum Immunoglobulin E, Serum Total Globulin, and Exhaled Nitric Oxide in Asthmatic Children","authors":"S.-W. Hu, A. J. Ghio","doi":"10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a1238","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a1238","url":null,"abstract":"","PeriodicalId":262576,"journal":{"name":"A31. REAL WORLD ASTHMA TREATMENT OUTCOMES, BIOMARKER STUDIES, PHENOTYPING, AND SEVERITY ASSESSMENTS","volume":"16 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127224413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Use of Inflammation Parameters in the Care of Patients with Asthma Prescribed Extrafine Single-Inhaler Triple Therapy: A Real-World View from Germany 使用炎症参数在哮喘患者的护理处方外单吸入器三联治疗:来自德国的现实世界的观点
A31. REAL WORLD ASTHMA TREATMENT OUTCOMES, BIOMARKER STUDIES, PHENOTYPING, AND SEVERITY ASSESSMENTS Pub Date : 2022-05-01 DOI: 10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a1239
C. Gessner, B. Akyıldız, D. Nachtigall, E. Nudo, S. Boeing, H. Timmermann
{"title":"The Use of Inflammation Parameters in the Care of Patients with Asthma Prescribed Extrafine Single-Inhaler Triple Therapy: A Real-World View from Germany","authors":"C. Gessner, B. Akyıldız, D. Nachtigall, E. Nudo, S. Boeing, H. Timmermann","doi":"10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a1239","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a1239","url":null,"abstract":"","PeriodicalId":262576,"journal":{"name":"A31. REAL WORLD ASTHMA TREATMENT OUTCOMES, BIOMARKER STUDIES, PHENOTYPING, AND SEVERITY ASSESSMENTS","volume":"3 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127590335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Eosinophil as a Determinant of Airway Hyperresponsiveness in Allergic Asthma with Elevated Blood Eosinophils 嗜酸性粒细胞作为过敏性哮喘患者气道高反应性的决定因素
A31. REAL WORLD ASTHMA TREATMENT OUTCOMES, BIOMARKER STUDIES, PHENOTYPING, AND SEVERITY ASSESSMENTS Pub Date : 2022-05-01 DOI: 10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a1247
M. Imaoka
{"title":"Eosinophil as a Determinant of Airway Hyperresponsiveness in Allergic Asthma with Elevated Blood Eosinophils","authors":"M. Imaoka","doi":"10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a1247","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a1247","url":null,"abstract":"","PeriodicalId":262576,"journal":{"name":"A31. REAL WORLD ASTHMA TREATMENT OUTCOMES, BIOMARKER STUDIES, PHENOTYPING, AND SEVERITY ASSESSMENTS","volume":"131 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124007644","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
30-Days Spirometry Holter: An Effective Tool for Diagnosis and the Optimization of the Respiratory Diseases - Case Series 30天动态肺活量测定:诊断和优化呼吸系统疾病的有效工具-病例系列
A31. REAL WORLD ASTHMA TREATMENT OUTCOMES, BIOMARKER STUDIES, PHENOTYPING, AND SEVERITY ASSESSMENTS Pub Date : 2022-05-01 DOI: 10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a1244
L. Koltowski, M. Soliński, A. Mazur, M. Kowalczyk, M. Basza
{"title":"30-Days Spirometry Holter: An Effective Tool for Diagnosis and the Optimization of the Respiratory Diseases - Case Series","authors":"L. Koltowski, M. Soliński, A. Mazur, M. Kowalczyk, M. Basza","doi":"10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a1244","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a1244","url":null,"abstract":"","PeriodicalId":262576,"journal":{"name":"A31. REAL WORLD ASTHMA TREATMENT OUTCOMES, BIOMARKER STUDIES, PHENOTYPING, AND SEVERITY ASSESSMENTS","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126698123","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correlates of Positive Methacholine Challenge Tests 甲胆碱激发试验阳性的相关性
A31. REAL WORLD ASTHMA TREATMENT OUTCOMES, BIOMARKER STUDIES, PHENOTYPING, AND SEVERITY ASSESSMENTS Pub Date : 2022-05-01 DOI: 10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a1246
S. Patrawala, C. Arevalo Rodriguez, R. Kraude, S. Georas, S. Khurana
{"title":"Correlates of Positive Methacholine Challenge Tests","authors":"S. Patrawala, C. Arevalo Rodriguez, R. Kraude, S. Georas, S. Khurana","doi":"10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a1246","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a1246","url":null,"abstract":"","PeriodicalId":262576,"journal":{"name":"A31. REAL WORLD ASTHMA TREATMENT OUTCOMES, BIOMARKER STUDIES, PHENOTYPING, AND SEVERITY ASSESSMENTS","volume":"21 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115102459","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
National Differences in Real-World Outcomes with Mepolizumab Treatment for Patients with Severe Asthma: Results from the REALITI-A Study Mepolizumab治疗严重哮喘患者的真实世界结果的国家差异:来自REALITI-A研究的结果
A31. REAL WORLD ASTHMA TREATMENT OUTCOMES, BIOMARKER STUDIES, PHENOTYPING, AND SEVERITY ASSESSMENTS Pub Date : 2022-05-01 DOI: 10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a1232
J.K. Lee, F. Schleich, G. Canonica, X. Muñoz, R. Chaudhuri, F.E.-H. Lee, P. Howarth, R. Price, S. Yang, R. Jakes, A. Maxwell, R. Alfonso Cristancho
{"title":"National Differences in Real-World Outcomes with Mepolizumab Treatment for Patients with Severe Asthma: Results from the REALITI-A Study","authors":"J.K. Lee, F. Schleich, G. Canonica, X. Muñoz, R. Chaudhuri, F.E.-H. Lee, P. Howarth, R. Price, S. Yang, R. Jakes, A. Maxwell, R. Alfonso Cristancho","doi":"10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a1232","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a1232","url":null,"abstract":"","PeriodicalId":262576,"journal":{"name":"A31. REAL WORLD ASTHMA TREATMENT OUTCOMES, BIOMARKER STUDIES, PHENOTYPING, AND SEVERITY ASSESSMENTS","volume":"37 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124040195","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Omalizumab on Exacerbations and Glucocorticoid Use in Patients with Allergic Bronchopulmonary Aspergillosis: A Systematic Review and Meta-Analysis Omalizumab对过敏性支气管肺曲霉病患者病情加重和糖皮质激素使用的影响:系统评价和荟萃分析
A31. REAL WORLD ASTHMA TREATMENT OUTCOMES, BIOMARKER STUDIES, PHENOTYPING, AND SEVERITY ASSESSMENTS Pub Date : 2022-05-01 DOI: 10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a1235
W. Calhoun, M. Jin, J. Douglass, J. Elborn, R. Agarwal, S. Lazarewicz, M. Yan
{"title":"Effect of Omalizumab on Exacerbations and Glucocorticoid Use in Patients with Allergic Bronchopulmonary Aspergillosis: A Systematic Review and Meta-Analysis","authors":"W. Calhoun, M. Jin, J. Douglass, J. Elborn, R. Agarwal, S. Lazarewicz, M. Yan","doi":"10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a1235","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a1235","url":null,"abstract":"","PeriodicalId":262576,"journal":{"name":"A31. REAL WORLD ASTHMA TREATMENT OUTCOMES, BIOMARKER STUDIES, PHENOTYPING, AND SEVERITY ASSESSMENTS","volume":"5 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133155372","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Comparison of Clinical Efficacy Between Mepolizumab and Benralizumab in Severe Eosinophilic Asthma Mepolizumab与Benralizumab治疗重度嗜酸性哮喘的临床疗效比较
A31. REAL WORLD ASTHMA TREATMENT OUTCOMES, BIOMARKER STUDIES, PHENOTYPING, AND SEVERITY ASSESSMENTS Pub Date : 2022-05-01 DOI: 10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a1233
K. Okawa, T. Akamatsu, S. Sugiyama, K. Shiratori, H. Nakayasu, T. Masuda, S. Takahashi, Y. Kitahara, Y. Kishimoto, S. Sakurai, M. Saigusa, A. Yamamoto, S. Morita, K. Asada, T. Shirai
{"title":"Comparison of Clinical Efficacy Between Mepolizumab and Benralizumab in Severe Eosinophilic Asthma","authors":"K. Okawa, T. Akamatsu, S. Sugiyama, K. Shiratori, H. Nakayasu, T. Masuda, S. Takahashi, Y. Kitahara, Y. Kishimoto, S. Sakurai, M. Saigusa, A. Yamamoto, S. Morita, K. Asada, T. Shirai","doi":"10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a1233","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a1233","url":null,"abstract":"","PeriodicalId":262576,"journal":{"name":"A31. REAL WORLD ASTHMA TREATMENT OUTCOMES, BIOMARKER STUDIES, PHENOTYPING, AND SEVERITY ASSESSMENTS","volume":"71 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114472058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prediction of Allergic Skin Sensitization in Asthmatic Adolescents in a Nigerian City, Using Blood Eosinophil Values 利用血液嗜酸性粒细胞值预测尼日利亚城市哮喘青少年的过敏性皮肤致敏
A31. REAL WORLD ASTHMA TREATMENT OUTCOMES, BIOMARKER STUDIES, PHENOTYPING, AND SEVERITY ASSESSMENTS Pub Date : 2022-05-01 DOI: 10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a1245
C. Ndukwu, A. Ayuk, J. Elo-Ilo
{"title":"Prediction of Allergic Skin Sensitization in Asthmatic Adolescents in a Nigerian City, Using Blood Eosinophil Values","authors":"C. Ndukwu, A. Ayuk, J. Elo-Ilo","doi":"10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a1245","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a1245","url":null,"abstract":"","PeriodicalId":262576,"journal":{"name":"A31. REAL WORLD ASTHMA TREATMENT OUTCOMES, BIOMARKER STUDIES, PHENOTYPING, AND SEVERITY ASSESSMENTS","volume":"16 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125526015","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信